Weiwei Zhu, MS

Zhu_Weiwei__205x293.jpg

“I have a longstanding interest in using biostatistics to advance medical research. Working at KPWHRI gives me a great opportunity to contribute to challenging projects with rich, relevant data and make a national impact on health care systems.”

Weiwei Zhu, MS

Biostatistician III, Kaiser Permanente Washington Health Research Institute

Weiwei.Zhu@kp.org
206-442-5215

Biography

Weiwei Zhu, MS, joined Kaiser Permanente Washington Health Research Institute's Biostatistics Unit in 2009. She works closely with Senior Investigator Diana Miglioretti, PhD, to design studies, manage data, and conduct statistical analyses for the Breast Cancer Surveillance Consortium (BCSC)—the National Cancer Institute’s seven-site network of mammography researchers. She has been a key member of the BCSC Statistical Coordinating Center for almost 10 years. Her work studying the breast screening benefits and risks played an essential role in an American Cancer Society screening guideline change in 2015.

Ms. Zhu also works with Senior Investigator Denise Boudreau, PhD, to quantify the serious risks of misuse, abuse, and addiction associated with long-term opioid use.  This multi-site study will use electronic health record data and survey interviews to provide estimates of long-term opioid use risks in two cohorts.

After beginning her medical research career as an intern at the University of Texas MD Anderson Cancer Center in 2007, Ms. Zhu served as a biostatistician at the Moffitt Cancer Center and Research Institute in Florida.

Research interests and experience

 

Recent publications

Finkelstein S, Trotti A, Rao N, Reintgen D, Cruse W, Feun L, Sondak V, Yu D, Zhu W, Gwede C, DeConti R. The Florida Melanoma Trial I: a prospective multicenter phase I/II trial of postoperative hypofractionated adjuvant radiotherapy with concurrent interferon-alfa-2b in the treatment of advanced stage III melanoma with long-term toxicity follow-up. ISRN Immunology. 2012;2012:[10 p.]. doi:10.5402/2012/324235.

Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155(8):481-92. PubMed

Bello C, Yu D, Komrokji RS, Zhu W, Wetzstein GA, List AF, Lancet JE. Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome. Cancer. 2011 Apr 1;117(7):1463-9. doi: 10.1002/cncr.25598. Epub 2010 Nov 8. PubMed

Kharfan-Dabaja MA, Chavez JC, Yu D, Zhu W, Fernandez-Vertiz EI, Perkins J, Shapiro J, Bookout R, Perez L, Fernandez HF, Komrokji RS, Lancetf J, Brand L, Field T, Ayala E, Janssen W, List AF, Anasetti C. Severe hypoalbuminemia at day 90 predicts worse non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant. 2011 Mar;17(3):384-93. Epub 2010 Jul 22. PubMed

Mahajan K, Challa S, Coppola D, Lawrence H, Luo Y, Gevariya H, Zhu W, Chen YA, Lawrence NJ, Mahajan NP. Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity. Prostate. 2010 Sep 1;70(12):1274-85. PubMed

 

Research

Insomnia-phone-therapy-elderly-blog_1col.jpg

Phone therapy for insomnia shown to improve sleep

A study among Kaiser Permanente members with sleep problems and osteoarthritis shows promise for overcoming obstacles to treatment.

News

3-D_Mammography_1col.jpg

Race, income, education affect access to 3D mammography

The technology’s potential benefits to detect breast cancer earlier are not equally shared among all women, researchers find.